Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Retained Earnings (2016 - 2025)

INVO Fertility has reported Retained Earnings over the past 16 years, most recently at -$93.1 million for Q3 2025.

  • Quarterly Retained Earnings fell 46.61% to -$93.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$93.1 million through Sep 2025, down 46.61% year-over-year, with the annual reading at -$67.2 million for FY2024, 16.17% down from the prior year.
  • Retained Earnings was -$93.1 million for Q3 2025 at INVO Fertility, down from -$90.2 million in the prior quarter.
  • Over five years, Retained Earnings peaked at -$34.7 million in Q1 2021 and troughed at -$93.1 million in Q3 2025.
  • The 5-year median for Retained Earnings is -$54.6 million (2023), against an average of -$56.4 million.
  • Year-over-year, Retained Earnings dropped 13.37% in 2024 and then crashed 46.61% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$38.9 million in 2021, then decreased by 28.01% to -$49.8 million in 2022, then dropped by 16.14% to -$57.8 million in 2023, then decreased by 16.17% to -$67.2 million in 2024, then crashed by 38.61% to -$93.1 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Retained Earnings are -$93.1 million (Q3 2025), -$90.2 million (Q2 2025), and -$84.9 million (Q1 2025).